(Q36499443)

English

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma (English)

1 reference

Europe PubMed Central

14 August 2017

1 reference

based on heuristic

inferred from title

2

object named as

Dirk Hose

1 reference

Europe PubMed Central

14 August 2017

Hartmut Goldschmidt

14

object named as

Hartmut Goldschmidt

1 reference

Europe PubMed Central

14 August 2017

5

object named as

Michel Jourdan

1 reference

Europe PubMed Central

14 August 2017

author name string

Karène Mahtouk

1

1 reference

Europe PubMed Central

14 August 2017

Pierre Raynaud

3

1 reference

Europe PubMed Central

14 August 2017

Michael Hundemer

4

1 reference

Europe PubMed Central

14 August 2017

Eric Jourdan

6

1 reference

Europe PubMed Central

14 August 2017

Veronique Pantesco

7

1 reference

Europe PubMed Central

14 August 2017

Marion Baudard

8

1 reference

Europe PubMed Central

14 August 2017

John De Vos

9

1 reference

Europe PubMed Central

14 August 2017

Marion Larroque

10

1 reference

Europe PubMed Central

14 August 2017

Thomas Moehler

11

1 reference

Europe PubMed Central

14 August 2017

Jean-Francois Rossi

12

1 reference

Europe PubMed Central

14 August 2017

Thierry Rème

13

1 reference

Europe PubMed Central

14 August 2017

Bernard Klein

15

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

5 March 2007

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

109

1 reference

Europe PubMed Central

14 August 2017

4914-4923

1 reference

Europe PubMed Central

14 August 2017

11

1 reference

Europe PubMed Central

14 August 2017

Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Microarray-based understanding of normal and malignant plasma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Syndecans: proteoglycan regulators of cell-surface microdomains?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Heparanase affects adhesive and tumorigenic potential of human glioma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Survival and proliferation factors of normal and malignant plasma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Heparanase mediates cell adhesion independent of its enzymatic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Soluble syndecan-1 promotes growth of myeloma tumors in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Heparanase: a key enzyme involved in cell invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Cloning and functional expression of a human heparanase gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Activation molecules on human myeloma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

30 September 2017

Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

28 June 2018

Analysis of high density expression microarrays with signed-rank call algorithms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

21 September 2018

Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

21 September 2018

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

21 September 2018

A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2268882

21 September 2018

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum syndecan-1: a new independent prognostic marker in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High heparanase activity in multiple myeloma is associated with elevated microvessel density

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparanase promotes the spontaneous metastasis of myeloma cells to bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2006-08-043232

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36499443&oldid=2048573096"